SCHEMBL6566629

SCHEMBL6566629

CC(NC(=O)c1cc(NC(=O)Nc2ccccc2)ccc1OC(c1ccccc1)c1ccccc1)c1cccnc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 3/20 0.53
CYP2C9 P11712 2/20 0.53
LRRK2 Q5S007 1/20 0.52
KCNB1 Q14721 6/20 0.44
KCNA5 P22460 3/20 0.44
KCNH2 Q12809 3/20 0.44
KCNK2 O95069 2/20 0.44
HSD17B10 Q99714 1/20 0.44
MEN1 O00255 2/20 0.43
NPC1 O15118 2/20 0.43
KMT2A Q03164 2/20 0.43
RAB9A P51151 1/20 0.43
KCNB2 Q92953 1/20 0.43
KDM4E B2RXH2 2/20 0.43
EIF2S1 P05198 1/20 0.42
EIF2AK3 Q9NZJ5 1/20 0.42
PTGDR2 Q9Y5Y4 1/20 0.42
IMPDH2 P12268 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567998 0.82 L3MBTL1 (0.53) NAMPTCYP2C9MEN1NPC1KMT2A
SCHEMBL6565938 0.81 CNR1 (0.44) HSD17B10MEN1NPC1KMT2ARAB9A
SCHEMBL6566630 0.80 PRMT3 (0.46) NAMPTLRRK2MEN1NPC1KMT2A
SCHEMBL6568006 0.80 KCNB1 (0.43) KCNB1KCNA5KCNH2KCNK2HSD17B10
SCHEMBL6564429 0.78 KMT2A (0.49) HSD17B10MEN1NPC1KMT2ARAB9A
SCHEMBL6567978 0.77 MEN1 (0.45) NAMPTLRRK2KCNA5HSD17B10MEN1
SCHEMBL6567867 0.77 KMT2A (0.44) LRRK2HSD17B10MEN1NPC1KMT2A
SCHEMBL6564786 0.77 KMT2A (0.61) CYP2C9HSD17B10MEN1NPC1KMT2A
SCHEMBL6566980 0.77 KMT2A (0.52) MEN1KMT2ARAB9A
SCHEMBL6567749 0.77 HTT (0.54) NAMPTMEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 NAMPT 3240/4885CYP2C9 310/4885LRRK2 2705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.